With more-advanced renal failure, phosphate binders become necessary to maintain phosphate balance and to prevent hyperphosphatemia. Because of toxicity, aluminum-containing phosphate binders are ...

In chronic kidney disease (CKD), the calcium–PTH–vitamin ... In addition, we discuss the effects of newer phosphate binders and calcium-receptor agonists on the future application of vitamin ...

rather than aluminium-containing oral phosphate binders. Limited evidence suggests that aluminium bone disease may also be on the decline in the era of aluminium removal from dialysis fluid ...

Chronic kidney ... kidney disease. Accumulating evidence from mouse studies suggests that cardiovascular calcification is not simply dependent on serum concentrations of calcium and phosphate ...

A change in Medicare coverage for some dialysis medications has left nursing homes and their patients receiving in-house treatment for kidney failure in a serious bind.

Nonadherence to phosphate binders is a significant challenge ... the treatment of hyperphosphatemia in patients with chronic kidney disease (CKD). OLC has over forty issued and granted patents ...

(Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the ... on the limitations of current phosphate binders and their effect on patients ...

In their comprehensive article, the authors present “special aspects of medication therapy in renal failure ... I doubt whether calcium-free phosphate binders such as sevelamer or lanthanum ...

(Nasdaq: UNCY), a biotech company focusing on kidney disease treatments with a current ... attention to the high non-adherence rates to phosphate binders, which are crucial in managing ...

Nonadherence to phosphate binders is a significant challenge contributing to elevated phosphate levels ... Hyperphosphatemia is a serious medical condition that occurs in nearly all patients with End ...